PRESS RELEASE published on 07/01/2024 at 07:00, 1 year 11 months ago Biophytis presented its Phase 2-3 COVA study results in severe forms of Covid-19 at the WCID in Paris Biophytis presents positive results from Phase 2-3 COVA study for severe Covid-19 at WCID Paris. Bio101 shows significant efficacy and safety in reducing risk of respiratory failure and death Biophytis COVID-19 Positive Results Phase 2-3 COVA Study Respiratory Failure
PRESS RELEASE published on 07/01/2024 at 07:00, 1 year 11 months ago Biophytis a présenté les résultats de l'étude COVA de phase 2-3 dans les formes sévères de Covid-19 lors du WCID à Paris Biophytis présente les résultats de l'étude COVA de phase 2-3 sur le traitement du Covid-19 lors du WCID à Paris. Les résultats sont positifs avec réduction significative des risques Biophytis COVID-19 COVA Résultats Phase 2-3
REGULATED PRESS RELEASE published on 07/01/2024 at 07:00, 1 year 11 months ago Biophy(s a présenté les résultats de l'étude COVA de phase 2-3 dans les formes sévères de Covid-19 lors du WCID à Paris Biophytis présente les résultats de l'étude COVA de phase 2-3 sur les formes sévères de Covid-19 lors du WCID à Paris. Des résultats positifs de réduction du risque de défaillance respiratoire et de mortalité sont révélés Biophytis COVID-19 Résultats Positifs Étude COVA Réduction Du Risque De Mortalité
REGULATED PRESS RELEASE published on 07/01/2024 at 07:00, 1 year 11 months ago Biophytis presented its Phase 2-3 COVA study results in severe forms of Covid-19 at the WCID in Paris Biophytis presented positive results of its Phase 2-3 COVA study for severe Covid-19 at WCID in Paris, showing reduction in respiratory failure and death rates Biophytis COVID-19 Positive Results Phase 2-3 COVA Study
BRIEF published on 06/25/2024 at 23:05, 1 year 11 months ago Biophytis Approves All Resolutions at General Meeting Shareholders Biophytis General Meeting Resolutions
BRIEF published on 06/25/2024 at 23:05, 1 year 11 months ago Résultats de l'Assemblée Générale Mixte de Biophytis du 24 juin 2024 Biophytis Assemblée Générale Resolutions Quorum Vote
REGULATED PRESS RELEASE published on 06/25/2024 at 23:00, 1 year 11 months ago RESULTS OF THE COMBINED GENERAL MEETING ON JUNE 24, 2024 Biophytis SA announces the approval of all resolutions at the combined general meeting held on June 24, 2024, with significant shareholder participation Shareholders General Meeting Resolutions Approval Biophytis SA
REGULATED PRESS RELEASE published on 06/25/2024 at 23:00, 1 year 11 months ago RÉSULTATS DE L’ASSEMBLÉE GÉNÉRALE MIXTE DU 24 JUIN 2024 Biophytis annonce l'approbation des résolutions lors de l'Assemblée Générale Mixte du 24 Juin 2024. Détails des décisions et perspectives de la société Biophytis Biotechnologie Assemblée Générale Mixte Approbation Des Résolutions Développement De Traitements
BRIEF published on 06/20/2024 at 07:05, 2 years ago Biophytis accorde à Blanver les droits exclusifs de BIO101 en Amérique Latine Biophytis Partenariat Amérique Latine BIO101 Blanver
BRIEF published on 06/20/2024 at 07:05, 2 years ago Biophytis Grants Blanver Exclusive Rights to BIO101 in Latin America in Deal Valued at Up to €108 Million Biophytis Pharmaceuticals Latin America BIO101 Blanver
Published on 06/24/2026 at 03:15, 4 hours 2 minutes ago Noram Lithium Adopts Semi-Annual Financial Reporting
Published on 06/24/2026 at 00:00, 7 hours 17 minutes ago Onco-Innovations Engages Nanosoft Polymers to Advance Polymer and Drug Delivery Development for ONC010
Published on 06/23/2026 at 23:45, 7 hours 32 minutes ago Prospect Ridge Aligns with the Market Mindset for Exclusive Live Investor Interview Discussing Game-changing 2026 Drill Programs
Published on 06/23/2026 at 23:20, 7 hours 57 minutes ago BioNxt Announces Closing of Non-brokered Private Placement of Units Pursuant to the Listed Issuer Exemption
Published on 06/23/2026 at 23:15, 8 hours 2 minutes ago EV Nickel Signs LOI Forming High-Grade Nickel Joint Venture for Shaw Dome Projects
Published on 06/24/2026 at 07:05, 11 minutes ago Malta's FIAU Reports Strengthened AML/CFT Preparedness, International Engagement and Operational Delivery in 2025
Published on 06/24/2026 at 07:01, 15 minutes ago TAG Immobilien AG: IPO of the Polish subsidiary ROBYG: successful share placement
Published on 06/24/2026 at 05:55, 1 hour 21 minutes ago Beyond Horizons, Forward Together | Kexing Biopharm Concludes Participation in CPHI & PMEC China 2026
Published on 06/24/2026 at 04:00, 3 hours 16 minutes ago Shipping edges closer to onboard carbon mineralisation as IMO endorses Shanghai Qiyao Technology Group Co., Ltd. proposals
Published on 06/24/2026 at 02:05, 5 hours 11 minutes ago FRONTERA AND KUPARI ANNOUNCE COMMENCEMENT OF STRATEGIC SALE PROCESS FOR THE JOINTLY OWNED PIEDRAS VERDES COPPER MINE COMPLEX IN SONORA, MEXICO
Published on 06/23/2026 at 19:47, 11 hours 29 minutes ago GROUPE SFPI: reorganisation de la Direction Générale
Published on 06/23/2026 at 19:47, 11 hours 29 minutes ago GROUPE SFPI: General management reorganisation
Published on 06/23/2026 at 19:10, 12 hours 6 minutes ago GUILLEMOT CORPORATION > EVOLUTION DE LA GOUVERNANCE A COMPTER DU 23 JUIN 2026
Published on 06/23/2026 at 19:10, 12 hours 6 minutes ago GUILLEMOT CORPORATION: Changes to Corporate Governance Effective June 23, 2026
Published on 06/23/2026 at 18:32, 12 hours 44 minutes ago Communiqué sur la demande de radiation auprès d'Euroclear des Droits à Complément de Prix